S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Saudi Arabia to cut oil output by 1 million barrels per day to boost slumping prices
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Chuck Todd says he's leaving 'Meet the Press' after a tumultuous near-decade moderating the NBC political panel show
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
Chuck Todd leaving NBC political panel show 'Meet the Press' and being replaced by Kristen Welker
“Amazon Loophole” could hand you $28,544 in “royalty” payouts (Ad)
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
Saudi Arabia to reduce oil output by 1 million barrels per day, while rest of OPEC+ extends previous cuts through 2024
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Saudi Arabia to cut oil output by 1 million barrels per day to boost slumping prices
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Chuck Todd says he's leaving 'Meet the Press' after a tumultuous near-decade moderating the NBC political panel show
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
Chuck Todd leaving NBC political panel show 'Meet the Press' and being replaced by Kristen Welker
“Amazon Loophole” could hand you $28,544 in “royalty” payouts (Ad)
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
Saudi Arabia to reduce oil output by 1 million barrels per day, while rest of OPEC+ extends previous cuts through 2024
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Saudi Arabia to cut oil output by 1 million barrels per day to boost slumping prices
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Chuck Todd says he's leaving 'Meet the Press' after a tumultuous near-decade moderating the NBC political panel show
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
Chuck Todd leaving NBC political panel show 'Meet the Press' and being replaced by Kristen Welker
“Amazon Loophole” could hand you $28,544 in “royalty” payouts (Ad)
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
Saudi Arabia to reduce oil output by 1 million barrels per day, while rest of OPEC+ extends previous cuts through 2024
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Saudi Arabia to cut oil output by 1 million barrels per day to boost slumping prices
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Chuck Todd says he's leaving 'Meet the Press' after a tumultuous near-decade moderating the NBC political panel show
Sell Every Stock, Except ONE (Ticker Revealed) (Ad)
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
Chuck Todd leaving NBC political panel show 'Meet the Press' and being replaced by Kristen Welker
“Amazon Loophole” could hand you $28,544 in “royalty” payouts (Ad)
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
Saudi Arabia to reduce oil output by 1 million barrels per day, while rest of OPEC+ extends previous cuts through 2024

R1 RCM (RCM) Stock Forecast, Price & News

$16.81
+0.38 (+2.31%)
(As of 06/2/2023 ET)
Compare
Today's Range
$16.49
$16.83
50-Day Range
$14.45
$16.91
52-Week Range
$6.71
$27.07
Volume
1.48 million shs
Average Volume
2.32 million shs
Market Capitalization
$7.03 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$17.44

R1 RCM MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.87 Rating Score
Upside/​Downside
3.7% Upside
$17.44 Price Target
Short Interest
Bearish
10.94% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.33
Upright™ Environmental Score
News Sentiment
0.93mentions of R1 RCM in the last 14 days
Based on 4 Articles This Week
Insider Trading
Selling Shares
$327,200 Sold Last Quarter
Proj. Earnings Growth
337.50%
From $0.08 to $0.35 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.00 out of 5 stars

Business Services Sector

195th out of 337 stocks

Management Services Industry

4th out of 6 stocks


RCM stock logo

About R1 RCM (NASDAQ:RCM) Stock

R1 RCM, Inc. engages in the provision of revenue cycle management to healthcare providers. It offers end-to-end, modular revenue cycle, and physician advisory services. The company was founded by Mary Ann Tolan and J. Michael Cline in July 2003 and is headquartered in Murray, UT.

Receive RCM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for R1 RCM and its competitors with MarketBeat's FREE daily newsletter.

RCM Stock News Headlines

R1 Rcm (NASDAQ: RCM)
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
R1 RCM (NASDAQ:RCM) Shares Gap Up Following Analyst Upgrade
R1 RCM (RCM) Receives a Buy from Bank of America Securities
NOTICE: Your retirement is in immediate danger
Soon you may be forced to spend your afternoons packing grocery bags at Walmart instead of going to the park with your grandchildren. Why? Because not only could your money be worth even less than it already is now, but certain stocks and cryptocurrencies could drop by 80%. Even your social security check could be worth 21% less! Learn how to protect your retirement here >>>
Robert W. Baird Reaffirms Their Buy Rating on R1 RCM (RCM)
R1 RCM Inc.: R1 RCM Reports First Quarter 2023 Results
R1 RCM: Q1 Earnings Insights
R1 RCM Reports First Quarter 2023 Results
See More Headlines

RCM Price History

RCM Company Calendar

Last Earnings
2/16/2023
Today
6/04/2023
Next Earnings (Estimated)
8/02/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Management services
Sub-Industry
Health Care Services
Current Symbol
NASDAQ:RCM
CUSIP
00438V10
Employees
27,800
Year Founded
2003

Price Target and Rating

Average Stock Price Forecast
$17.44
High Stock Price Forecast
$25.00
Low Stock Price Forecast
$10.00
Forecasted Upside/Downside
+3.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.87
Research Coverage
15 Analysts

Profitability

Net Income
$-57,600,000.00
Pretax Margin
-4.91%

Debt

Sales & Book Value

Annual Sales
$1.81 billion
Cash Flow
$0.29 per share
Book Value
$6.50 per share

Miscellaneous

Free Float
263,468,000
Market Cap
$7.03 billion
Optionable
Not Optionable
Beta
0.84

Social Links


Key Executives

  • Lee Rivas
    Chief Executive Officer & Director
  • John SparbyJohn Sparby
    President
  • Kristina Bourke
    Executive Vice President-Operations
  • Jennifer Williams
    Chief Financial Officer & EVP
  • Harvey Ewing
    Chief Information Officer & Executive VP













RCM Stock - Frequently Asked Questions

Should I buy or sell R1 RCM stock right now?

15 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for R1 RCM in the last twelve months. There are currently 2 hold ratings and 13 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" RCM shares.
View RCM analyst ratings
or view top-rated stocks.

What is R1 RCM's stock price forecast for 2023?

15 Wall Street analysts have issued 1-year target prices for R1 RCM's stock. Their RCM share price forecasts range from $10.00 to $25.00. On average, they predict the company's stock price to reach $17.44 in the next year. This suggests a possible upside of 3.7% from the stock's current price.
View analysts price targets for RCM
or view top-rated stocks among Wall Street analysts.

How have RCM shares performed in 2023?

R1 RCM's stock was trading at $10.95 at the beginning of 2023. Since then, RCM shares have increased by 53.5% and is now trading at $16.81.
View the best growth stocks for 2023 here
.

When is R1 RCM's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 2nd 2023.
View our RCM earnings forecast
.

How were R1 RCM's earnings last quarter?

R1 RCM Inc. (NASDAQ:RCM) posted its quarterly earnings data on Thursday, February, 16th. The healthcare provider reported ($0.09) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.03) by $0.06. The healthcare provider had revenue of $532.80 million for the quarter, compared to the consensus estimate of $519.28 million. R1 RCM had a negative trailing twelve-month return on equity of 1.02% and a negative net margin of 4.41%. R1 RCM's revenue was up 33.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.11 earnings per share.

What guidance has R1 RCM issued on next quarter's earnings?

R1 RCM updated its FY 2023 earnings guidance on Thursday, May, 4th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $2.28 billion-$2.33 billion, compared to the consensus revenue estimate of $2.31 billion.

What is Joseph Flanagan's approval rating as R1 RCM's CEO?

253 employees have rated R1 RCM Chief Executive Officer Joseph Flanagan on Glassdoor.com. Joseph Flanagan has an approval rating of 70% among the company's employees.

What other stocks do shareholders of R1 RCM own?

Based on aggregate information from My MarketBeat watchlists, some companies that other R1 RCM investors own include NVIDIA (NVDA), JD.com (JD), Baozun (BZUN), Inseego (INSG), BioXcel Therapeutics (BTAI), Marvell Technology (MRVL), Akoustis Technologies (AKTS), Alibaba Group (BABA), Bilibili (BILI) and Model N (MODN).

What is R1 RCM's stock symbol?

R1 RCM trades on the NASDAQ under the ticker symbol "RCM."

Who are R1 RCM's major shareholders?

R1 RCM's stock is owned by a number of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (4.22%), FMR LLC (1.91%), Sachem Head Capital Management LP (1.78%), American Century Companies Inc. (1.77%), Bank of New York Mellon Corp (1.53%) and State Street Corp (1.18%). Insiders that own company stock include Achi Series Lllp Tcp-Asc, Alex Mandl, Gary Steven Long, John M Sparby, Joseph Gerard Flanagan, Lee Rivas, Michael C Feiner and Richard B Jr Evans.
View institutional ownership trends
.

How do I buy shares of R1 RCM?

Shares of RCM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is R1 RCM's stock price today?

One share of RCM stock can currently be purchased for approximately $16.81.

How much money does R1 RCM make?

R1 RCM (NASDAQ:RCM) has a market capitalization of $7.03 billion and generates $1.81 billion in revenue each year. The healthcare provider earns $-57,600,000.00 in net income (profit) each year or ($0.23) on an earnings per share basis.

How many employees does R1 RCM have?

The company employs 27,800 workers across the globe.

Does R1 RCM have any subsidiaries?
The following companies are subsidiares of R1 RCM: Accretive Health Mauritius Inc., Cerner RevWorks, Clearsight Intermediate Holdings Inc., Cloudmed, Flare Capital Partners Investment Company, Intermedix, Intermedix ARM LLC, Intermedix Corporation, Intermedix Holdings Inc., Intermedix Lietuva UAB, Intermedix Midco Inc., Intermedix Office Based LLC, Intermedix Staffing Inc., Medical Consultants Inc., Practice Support Resources LLC, Project Links Parent Inc., Project Roadrunner Merger Sub Inc., Project Roadrunner Parent Inc., R1 RCM Global Private Limited, R1 RCM India Private Limited, Rover16 Inc., SCHEDULING.COM INC., SCI Solutions, Tonic Health LLC, VisitPay, cGate Health Inc., and iVinci Partners LLC.
Read More
How can I contact R1 RCM?

R1 RCM's mailing address is 401 NORTH MICHIGAN AVENUE SUITE 2700, CHICAGO IL, 60611. The official website for the company is www.r1rcm.com. The healthcare provider can be reached via phone at (312) 324-7820, via email at arahim@r1rcm.com, or via fax at 302-655-5049.

This page (NASDAQ:RCM) was last updated on 6/4/2023 by MarketBeat.com Staff

My Account -